Interleukin-15 mediates protection against experimental tuberculosis: a role for NKG2D-dependent effector mechanisms of CD8+ T cells

European Journal of Immunology
Alexandra RauschChristoph Hölscher

Abstract

CD8+ T cells are involved in protection against Mycobacterium tuberculosis infection and represent a promising target for new vaccine strategies. Because IL-15 is important for the homeostasis of CD8+ T cells, we studied the immune response in IL-15-deficient mice during tuberculosis. In the absence of IL-15, CD8+ T cells failed to efficiently accumulate in draining lymph nodes and at the site of infection. The expression of antigen-specific effector functions, such as the production of interferon-gamma and cytotoxicity, were impaired in CD8+ T cells, but not CD4+ T cells, from IL-15-deficient mice. This defect was associated with an increased mortality of IL-15-deficient mice during the chronic phase of infection. The lectin-like stimulatory receptor natural killer group 2D (NKG2D) was up-regulated on CD8+ T cells only from wild-type mice, but not from IL-15-deficient mice. Mechanistically, blocking NKG2D function with an mAb inhibited M. tuberculosis-directed CD8+ T cell responses in vitro. We conclude that in addition to regulating the expansion of CD8+ T cells, IL-15 is also necessary for inducing effector mechanisms in CD8+ T cells that depend on NKG2D expression. Hence, our results implicate IL-15 and NKG2D as promising t...Continue Reading

References

Mar 1, 1995·The Journal of Experimental Medicine·P C Wilkinson, F Y Liew
Mar 8, 2000·The Journal of Experimental Medicine·M K KennedyJ J Peschon
Apr 13, 2000·Proceedings of the National Academy of Sciences of the United States of America·A O SousaB R Bloom
Jun 22, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·N V SerbinaJ L Flynn
Jan 3, 2001·Blood·T A Fehniger, M A Caligiuri
Feb 13, 2001·European Journal of Immunology·L A van PinxterenP Andersen
Mar 13, 2001·Annual Review of Immunology·J L Flynn, J Chan
Jun 13, 2001·Infection and Immunity·N V Serbina, J L Flynn
Jul 7, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·M UmemuraY Yoshikai
Nov 8, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A I RobertsB Jabri
Jan 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Toshiki YajimaYasunobu Yoshikai
Mar 22, 2002·Nature Reviews. Immunology·S H Kaufmann
May 8, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kimberly S SchlunsLeo Lefrançois
Jun 19, 2002·The Journal of Experimental Medicine·Ananda W GoldrathEric A Butz
Jun 19, 2002·The Journal of Experimental Medicine·Todd C BeckerRafi Ahmed
Oct 9, 2002·The Journal of Experimental Medicine·Adam D JudgeJonathan Sprent
Oct 16, 2002·American Journal of Respiratory and Critical Care Medicine·Vanja Lazarevic, JoAnne Flynn
Nov 12, 2002·Nature Immunology·Susan GilfillanMarco Colonna
Apr 2, 2003·Nature Reviews. Immunology·Kimberly S Schluns, Leo Lefrançois
Apr 3, 2003·Proceedings of the National Academy of Sciences of the United States of America·Patrick R BurkettDavid L Boone
May 8, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Marion BerardDavid F Tough
Jun 17, 2003·Nature Immunology·Benedict SeddonRose Zamoyska
Oct 3, 2003·Nature Reviews. Immunology·David H Raulet
Oct 25, 2003·Science·John D MacMickingJohn D McKinney
Nov 11, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yvan ChapdelaineSubash Sad
Nov 25, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ana Paula Junqueira-KipnisIan M Orme
Feb 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jessica A HamermanLewis L Lanier
Aug 6, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Joshua J ObarEdward J Usherwood
Oct 27, 2004·Infection and Immunity·Linda A LiebermanChristopher A Hunter
Mar 8, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Christoph HölscherStefan Ehlers
Apr 9, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kerima MaashoFrancisco Borrego

❮ Previous
Next ❯

Citations

Oct 7, 2008·Oncogene·N Nausch, A Cerwenka
Nov 21, 2007·Blood·Young-June KimHal E Broxmeyer
Oct 24, 2006·Trends in Microbiology·Rosangela Salerno-Gonçalves, Marcelo B Sztein
Oct 2, 2009·European Journal of Immunology·Martin BeisiegelStefan H E Kaufmann
Nov 17, 2015·Nature Reviews. Immunology·Bana Jabri, Valérie Abadie
Jun 22, 2016·Cytokine & Growth Factor Reviews·Manoj PatidarSarat K Dalai
Sep 14, 2017·Journal of Molecular Microbiology and Biotechnology·Federico Carlos BlancoFabiana Bigi
Feb 7, 2009·Expert Review of Vaccines·Luiz Rodrigues, Cristina Bonorino
Jun 21, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hongbing GuanImtiaz A Khan
May 10, 2018·Frontiers in Immunology·Ana StojanovicAdelheid Cerwenka
Aug 2, 2020·The Journal of Investigative Dermatology·Fernanda O NovaisPhillip Scott

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.